Africa CDC Hails Nigeria's Health Reform Model
Africa CDC hails Nigeria's health sector reforms as continental model. Nigeria to pilot G20 health financing. Learn how this impacts universal health coverage.
Africa CDC hails Nigeria's health sector reforms as continental model. Nigeria to pilot G20 health financing. Learn how this impacts universal health coverage.
US judge approves Purdue Pharma bankruptcy, dissolving OxyContin maker. Sacklers pay $6.5-7B settlement. Learn about Nigeria's opioid awareness.
Pfizer completes Metsera acquisition worth up to $10 billion, entering the competitive weight loss drug market. Learn how this deal positions Pfizer against Novo Nordisk.
German giant Bayer reports a narrower Q3 loss of €963 million and expresses confidence in containing Roundup litigation risks by end of 2026. Discover the details.
Federal Government partners with European Union and UNICEF in groundbreaking €6.3 million initiative to boost local manufacturing of essential health commodities and reduce import dependency.
Federal Government signs landmark agreement to strengthen local manufacturing of essential health commodities, reducing import dependency and creating jobs.
British-Swedish pharmaceutical giant AstraZeneca reports massive profit jump with 19% revenue growth. Discover how emerging markets and cancer drugs drove this impressive performance.
Neimeth International Pharmaceuticals records massive 120% operating profit growth as strategic marketing expansion and cost management deliver outstanding results in Nigerian healthcare sector.
NAFDAC's Director-General Prof. Moji Adeyeye earns commendation for transformational leadership that's reshaping Nigeria's healthcare landscape and regulatory standards.
Edo State announces groundbreaking pharmaceutical manufacturing initiative to produce essential medicines locally by 2026, reducing import dependency and creating thousands of jobs.
Global pharmaceutical giant Pfizer experiences significant profit decline amid falling COVID-19 product sales. Analysis of impact on Nigerian healthcare market and future outlook.
Massive €10.2 million investment aims to boost local drug manufacturing, reduce import dependency, and create thousands of jobs in Nigeria's healthcare sector.
Breaking: European Union and France launch massive €10.2 million investment to transform Nigeria's local drug manufacturing capacity and healthcare security.
ACPN demands immediate government action against unlicensed drug distribution in healthcare facilities, warning of dire consequences for patient safety and public health.
President Tinubu's administration takes decisive action to revolutionize Nigeria's pharmaceutical sector with new policies aimed at boosting local medicine manufacturing and reducing import dependency.
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.
British drugmaker GSK raises 2025 profit guidance as Nigeria's tariff reforms create favorable market conditions. Discover how this impacts healthcare costs and medicine availability.